アステラス製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/09/14 | 2,185.5 | 2,210 | 2,180.5 | 2,202.5 | +15 | +0.7% | 5,737,500 |
2023/09/13 | 2,199 | 2,202 | 2,185 | 2,187.5 | -2 | -0.1% | 4,885,000 |
2023/09/12 | 2,178.5 | 2,202 | 2,175 | 2,189.5 | +5 | +0.2% | 3,695,700 |
2023/09/11 | 2,215.5 | 2,219 | 2,182.5 | 2,184.5 | -30 | -1.4% | 4,172,100 |
2023/09/08 | 2,212 | 2,233 | 2,200 | 2,214.5 | +7 | +0.3% | 7,658,800 |
2023/09/07 | 2,220 | 2,229.5 | 2,207 | 2,207.5 | -15.5 | -0.7% | 6,570,700 |
2023/09/06 | 2,220 | 2,241 | 2,216 | 2,223 | +7.5 | +0.3% | 4,961,300 |
2023/09/05 | 2,213 | 2,218 | 2,198.5 | 2,215.5 | -3.5 | -0.2% | 4,588,700 |
2023/09/04 | 2,205 | 2,219 | 2,194 | 2,219 | +19 | +0.9% | 3,558,200 |
2023/09/01 | 2,193.5 | 2,214.5 | 2,189.5 | 2,200 | -14.5 | -0.7% | 4,748,800 |
2023/08/31 | 2,177.5 | 2,223.5 | 2,176 | 2,214.5 | +8.5 | +0.4% | 10,767,100 |
2023/08/30 | 2,212.5 | 2,224 | 2,201 | 2,206 | +9.5 | +0.4% | 4,581,100 |
2023/08/29 | 2,198.5 | 2,211.5 | 2,195 | 2,196.5 | -7.5 | -0.3% | 3,922,000 |
2023/08/28 | 2,200 | 2,209.5 | 2,193.5 | 2,204 | +24 | +1.1% | 5,400,400 |
2023/08/25 | 2,195 | 2,211.5 | 2,180 | 2,180 | -31.5 | -1.4% | 6,586,500 |
2023/08/24 | 2,218.5 | 2,227 | 2,197 | 2,211.5 | -23 | -1% | 5,938,900 |
2023/08/23 | 2,235 | 2,239.5 | 2,213.5 | 2,234.5 | -4.5 | -0.2% | 5,822,000 |
2023/08/22 | 2,260.5 | 2,261.5 | 2,227 | 2,239 | -18.5 | -0.8% | 4,833,200 |
2023/08/21 | 2,237.5 | 2,268.5 | 2,236 | 2,257.5 | +26.5 | +1.2% | 5,007,800 |
2023/08/18 | 2,232 | 2,244 | 2,215 | 2,231 | -17 | -0.8% | 6,535,200 |
2023/08/17 | 2,224.5 | 2,250 | 2,220.5 | 2,248 | +16 | +0.7% | 7,485,700 |
2023/08/16 | 2,220.5 | 2,246.5 | 2,210.5 | 2,232 | +18.5 | +0.8% | 6,795,900 |
2023/08/15 | 2,223 | 2,225.5 | 2,199.5 | 2,213.5 | -10.5 | -0.5% | 5,150,300 |
2023/08/14 | 2,259 | 2,270 | 2,222.5 | 2,224 | -23.5 | -1% | 6,769,800 |
2023/08/10 | 2,180 | 2,247.5 | 2,180 | 2,247.5 | +69.5 | +3.2% | 9,428,000 |
2023/08/09 | 2,180.5 | 2,190 | 2,153 | 2,178 | +18 | +0.8% | 6,516,300 |
2023/08/08 | 2,145 | 2,174.5 | 2,132.5 | 2,160 | -31 | -1.4% | 9,712,100 |
2023/08/07 | 2,107.5 | 2,193.5 | 2,086.5 | 2,191 | +200 | +10% | 17,498,600 |
2023/08/04 | 1,991 | 1,998 | 1,976.5 | 1,991 | -20 | -1% | 5,381,000 |
2023/08/03 | 2,060 | 2,061 | 2,009.5 | 2,011 | -46 | -2.2% | 7,088,300 |
2023/08/02 | 2,080.5 | 2,082.5 | 2,034.5 | 2,057 | -73.5 | -3.4% | 10,430,400 |
2023/08/01 | 2,095 | 2,135 | 2,088 | 2,130.5 | +50 | +2.4% | 7,896,200 |
2023/07/31 | 2,102 | 2,127 | 2,079 | 2,080.5 | +0.5 | ±0% | 7,759,100 |
2023/07/28 | 2,087.5 | 2,092.5 | 2,045 | 2,080 | -28 | -1.3% | 7,850,700 |
2023/07/27 | 2,095.5 | 2,109 | 2,076 | 2,108 | +14 | +0.7% | 5,833,400 |
2023/07/26 | 2,093 | 2,102.5 | 2,089.5 | 2,094 | +14 | +0.7% | 3,542,100 |
2023/07/25 | 2,111.5 | 2,116 | 2,068.5 | 2,080 | -23 | -1.1% | 4,687,100 |
2023/07/24 | 2,098 | 2,107.5 | 2,084 | 2,103 | +25.5 | +1.2% | 4,289,800 |
2023/07/21 | 2,070 | 2,092.5 | 2,062.5 | 2,077.5 | +7 | +0.3% | 5,051,600 |
2023/07/20 | 2,069 | 2,082 | 2,052 | 2,070.5 | +12.5 | +0.6% | 6,572,000 |
2023/07/19 | 2,038 | 2,059 | 2,024.5 | 2,058 | +43 | +2.1% | 5,295,100 |
2023/07/18 | 2,011 | 2,028.5 | 2,004 | 2,015 | +10 | +0.5% | 5,961,100 |
2023/07/14 | 1,983 | 2,029 | 1,983 | 2,005 | -3.5 | -0.2% | 6,373,400 |
2023/07/13 | 2,006.5 | 2,024.5 | 1,999 | 2,008.5 | -13.5 | -0.7% | 4,349,000 |
2023/07/12 | 2,040 | 2,042 | 2,001.5 | 2,022 | -27.5 | -1.3% | 5,957,400 |
2023/07/11 | 2,052.5 | 2,061 | 2,041 | 2,049.5 | +11.5 | +0.6% | 5,615,400 |
2023/07/10 | 2,060 | 2,071 | 2,020 | 2,038 | -23 | -1.1% | 7,562,300 |
2023/07/07 | 2,060 | 2,077.5 | 2,028 | 2,061 | +9 | +0.4% | 7,733,500 |
2023/07/06 | 2,092 | 2,092.5 | 2,042 | 2,052 | -32 | -1.5% | 5,945,600 |
2023/07/05 | 2,090 | 2,098.5 | 2,081.5 | 2,084 | +0.5 | ±0% | 4,655,800 |
401~
450
件表示中 / 3695件
類似銘柄と比較する
現在ご覧いただいている「アステラス薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アステラス薬 | 139,600円 | +0.9% | +380.2% | 5.59% | 19.23倍 | 1.65倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
武 田 | 423,400円 | -1.1% | +75.3% | 4.72% | 29.00倍 | 0.95倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 707,500円 | +2.2% | +10.2% | 1.70% | 13.59倍 | 1.37倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
塩野義 | 240,500円 | +5.7% | +3.9% | 2.55% | 11.97倍 | 1.58倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 405,000円 | +1.7% | -2.9% | 3.95% | 26.57倍 | 1.39倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム